Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
To determine the concentration of 9-nitrocamptothecin (9NC) in the alveolar fluid over time.
1.2. To determine the arterial concentration of 9NC administered by inhalation in comparison
to venous and urine concentrations.
1.3. To determine the tumor concentration of 9NC administered by inhalation